Loading people...
David Spreng is the founder, CEO, and CIO of Runway Growth Capital, a prominent venture debt firm. He is a seasoned investor with decades of experience providing capital to late and growth-stage technology and life sciences companies.
David Spreng, through Runway Growth Capital, primarily invests in late and growth-stage companies across the technology and life sciences sectors. This includes enterprise software, fintech, healthcare IT, consumer internet, therapeutics, medical devices, and digital health solutions, primarily through venture debt financing.
David Spreng works at Runway Growth Capital, where he serves as the founder, Chief Executive Officer, and Chief Investment Officer. Runway Growth Capital is headquartered in Woodside, California, with additional offices.
David Spreng stands as a prominent figure in the venture debt landscape, recognized as the founder, Chief Executive Officer, and Chief Investment Officer of Runway Growth Capital. Under his astute leadership, Runway Growth Capital has established itself as a crucial financial partner for late and growth-stage companies seeking non-dilutive capital solutions. Spreng's strategic vision has positioned the firm to provide tailored venture debt financing, enabling innovative businesses to accelerate their growth, expand operations, and achieve key milestones without significant equity dilution.
Spreng's investment focus at Runway Growth Capital is primarily directed towards high-growth sectors, particularly technology and life sciences. Within technology, this encompasses a broad spectrum including enterprise software, fintech, healthcare IT, and consumer internet companies. In life sciences, Runway supports businesses developing groundbreaking therapeutics, medical devices, and digital health solutions. His approach is characterized by a deep understanding of these industries' unique capital requirements and growth trajectories, allowing him to identify companies with strong market potential and robust business models that are ripe for strategic investment.
David Spreng's career background is marked by a consistent dedication to venture debt and technology finance. Before founding Runway Growth Capital, he built and led other highly successful venture debt platforms, including Western Technology Investment (WTI), which he founded and managed for many years. This extensive experience has provided him with unparalleled insights into the dynamics of venture-backed companies and the critical role that flexible debt financing plays in their success. His leadership has consistently focused on fostering long-term relationships with entrepreneurs and venture capital partners, building a reputation for reliability and strategic support within the investment community.
Throughout his distinguished career, Spreng has been instrumental in providing capital to hundreds of companies, helping them navigate various stages of development from early growth to pre-IPO. While specific individual investments are often confidential in the venture debt space, his impact is evident in the collective success of numerous companies that have leveraged Runway Growth Capital's financing to scale operations, fund research and development, and execute strategic acquisitions. His work continues to shape the growth trajectories of innovative companies, solidifying his legacy as a pivotal investor in the technology and life sciences ecosystems.
David Spreng is the Founder, Chief Executive Officer, and Chief Investment Officer of Runway Growth Capital, based in the San Francisco Bay Area. Since establishing the firm in 2015 with a strategic partnership from Oaktree Capital Management, he has grown its assets under management to over $1 billion and led its 2021 initial public offering on the Nasdaq. Prior to this venture debt focus, he spent three decades in equity investing, notably as the Co-Founder and Managing Partner of Crescendo Ventures, where he managed over $1 billion across multiple funds. His earlier career included investment banking at Salomon Brothers in New York, and his venture capital activities have backed approximately 50 technology companies, resulting in 18 initial public offerings. Spreng currently focuses his efforts on providing minimally dilutive senior term loans to late-stage technology and life sciences companies.
